Conduit Pharmaceuticals Files 8-K on Shareholder Nominations
Ticker: CDTTW · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-nomination, corporate-governance, 8-k
Related Tickers: CDT
TL;DR
Conduit Pharma (CDT) filed an 8-K for shareholder nominations - board shakeup incoming?
AI Summary
Conduit Pharmaceuticals Inc. filed an 8-K on June 3, 2025, to report shareholder nominations pursuant to Exchange Act Rule 14a-11. The company, formerly known as Murphy Canyon Acquisition Corp. until November 30, 2021, is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing indicates potential changes or activism regarding the composition of Conduit Pharmaceuticals' board of directors, which could impact the company's strategic direction.
Risk Assessment
Risk Level: medium — Shareholder nominations can signal activism or disputes, potentially leading to changes in company leadership and strategy.
Key Players & Entities
- Conduit Pharmaceuticals Inc. (company) — Registrant
- Murphy Canyon Acquisition Corp. (company) — Former company name
- November 30, 2021 (date) — Date of name change
- June 3, 2025 (date) — Date of report
- Exchange Act Rule 14a-11 (legal_document) — Regulation cited for shareholder nominations
FAQ
What is the specific purpose of the shareholder nominations being reported?
The filing states the nominations are pursuant to Exchange Act Rule 14a-11, which pertains to shareholder nominations of directors.
When did Conduit Pharmaceuticals Inc. change its name from Murphy Canyon Acquisition Corp.?
The company changed its name on November 30, 2021.
What is the primary business of Conduit Pharmaceuticals Inc.?
The company is classified under Pharmaceutical Preparations (SIC code 2834).
In which state is Conduit Pharmaceuticals Inc. incorporated?
Conduit Pharmaceuticals Inc. is incorporated in Delaware.
What is the filing date of this 8-K report?
The report was filed on June 3, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding CONDUIT PHARMACEUTICALS INC. (CDTTW).